Adefovir dipivoxil
Showing 1 - 25 of 162
Chronic Hepatitis B Trial (Adefovir Dipivoxil)
Completed
- Chronic Hepatitis B
- Adefovir Dipivoxil
- (no location specified)
Nov 5, 2021
HIV, Hepatitis B, Hepatitis C Trial (Adefovir dipivoxil, Peginterferon-alfa-2A, Ribavirin)
Withdrawn
- HIV Infections
- +2 more
- Adefovir dipivoxil
- +3 more
- (no location specified)
Oct 28, 2021
Hepatitis B, Liver Transplantation Trial in New York (Adefovir dipivoxil and hepatitis B vaccination)
Completed
- Hepatitis B
- Liver Transplantation
- Adefovir dipivoxil and hepatitis B vaccination
-
New York, New YorkCenter for Liver Disease and Transplantation at Columbia Univers
Aug 6, 2021
HIV, Hepatitis B Trial in United States (Adefovir dipivoxil, Tenofovir disoproxil fumarate)
Completed
- HIV Infections
- Hepatitis B
- Adefovir dipivoxil
- Tenofovir disoproxil fumarate
-
Sacramento, California
- +14 more
Oct 28, 2021
Chronic Hepatitis B Trial in Amsterdam (Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir
Completed
- Chronic Hepatitis B
- Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
-
Amsterdam, Noord-Holland, NetherlandsAcademic Medical Center
Mar 25, 2021
HIV Trial in Puerto Rico, United States (Indinavir sulfate, Abacavir sulfate, Amprenavir)
Completed
- HIV Infections
- Indinavir sulfate
- +7 more
-
Los Angeles, California
- +44 more
Oct 27, 2021
HIV Trial in Puerto Rico, United States (Indinavir sulfate, Abacavir sulfate, Nelfinavir mesylate)
Completed
- HIV Infections
- Indinavir sulfate
- +9 more
-
Birmingham, Alabama
- +52 more
Oct 27, 2021
Cirrhosis, Liver, Portal Hypertension Trial in Beijing, Shanghai (Carvedilol)
Recruiting
- Cirrhosis, Liver
- Portal Hypertension
-
Beijing, Beijing, China
- +5 more
Jan 26, 2022
Hepatitis B, Viral Hepatitis Trial in Taichung (Tenofovir alafenamide, Entecavir)
Recruiting
- Hepatitis B
- Viral Hepatitis
- Tenofovir alafenamide
- Entecavir
-
Taichung, TaiwanTaichung Veterans General Hospital
Feb 9, 2022
About Anti-viral Regimen Adjustment on Achieving Complete
Unknown status
- Sustained Virologic Response
- Hepatitis B, Chronic
- only monitoring
- +2 more
-
Chongqing, Chongqing, ChinaThe second affiliated Hospital of Chongqing Medical University
Aug 4, 2021
Liver Cirrhosis, Portal Hypertension Trial in China (Carvedilol 12.5 MG)
Recruiting
- Liver Cirrhosis
- Portal Hypertension
- Carvedilol 12.5 MG
-
Beijing, Beijing, China
- +13 more
Aug 19, 2021
Improvement of Hard Endpoint in Chronic Hepatitis B Patients
Active, not recruiting
- Chronic Hepatitis B
- Nucleos(t)ide Analogues
-
Beijing, Beijing, China
- +3 more
Apr 9, 2021
HIV-HBV Co-infected Patients in Southern Africa
Completed
- Hepatitis B Virus
- +5 more
- Standard of care
-
Lusaka, ZambiaCentre for Infectious Disease Research in Zambia
Nov 5, 2021
HBV Trial in Kaohsiung (Tenofovir Alafenamide Tablets)
Recruiting
- HBV
- Tenofovir Alafenamide Tablets
-
Kaohsiung, TaiwanKaohsiung Medical University Hospital
Dec 21, 2020
Renal Function of Patients With Chronic Hepatitis B in China
Unknown status
- Hepatitis B, Chronic
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Sun Yat-Sen University
Sep 3, 2020
Hepatitis B Trial in China (Tenofovir disoproxil fumarate (TDF) tablets, Adefovir dipivoxil (ADV) tablets)
Completed
- Hepatitis B
- Tenofovir disoproxil fumarate (TDF) tablets
- Adefovir dipivoxil (ADV) tablets
-
Guangzhou, Guangdong, China
- +19 more
Jun 13, 2018
Healthy Trial in Cologne (pitavastatin, Metformin, digoxin)
Completed
- Healthy
- pitavastatin
- +4 more
-
Cologne, NRW, GermanyDepartment of Pharmacology I, University Hospital Cologne
Sep 6, 2019
Hepatitis B, Chronic Trial in Shatin, New Territories (Lamivudine, Adefovir dipivoxil, Fixed dose combination (Lamivudine and
Completed
- Hepatitis B, Chronic
- Lamivudine
- +2 more
-
Shatin, New Territories, Hong KongGSK Investigational Site
Aug 2, 2017
Hepatitis B Trial run by the NIDDK (Tenofovir & Emtricitabine, Tenofovir)
Terminated
- Hepatitis B
- Tenofovir & Emtricitabine
- Tenofovir
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
May 23, 2019
HCC Patients After Curative Treatment With Low HBV Viral Load Trial in Kaohsiung, Taipei (Vemlidy® (Tenofovir Alafenamide; TAF),
Recruiting
- HCC Patients After Curative Treatment With Low HBV Viral Load
- Vemlidy® (Tenofovir Alafenamide; TAF)
- Placebo
-
Kaohsiung, State..., Taiwan
- +3 more
Jul 5, 2021
Hepatitis B, Chronic Trial in Guangzhou (Telbivudine, Adefovir dipivoxil)
Completed
- Hepatitis B, Chronic
- Telbivudine, Adefovir dipivoxil
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Sun Yat-sen University
Oct 22, 2017